Know About Dr. Abhishek Aggarwal
Dr. Abhishek Aggarwal is a highly skilled GI & HPB surgeon with over 10 years of experience in managing complex gastrointestinal and hepato-pancreato-biliary diseases, with a special focus on oncological surgery. He currently serves as Associate Director – GI Oncosurgery at BLK-Max Super Speciality Hospital, where he is actively involved in delivering advanced surgical care for GI and HPB malignancies.
He has trained and worked in reputed high-volume centres, gaining extensive expertise in complex oncological procedures and multidisciplinary cancer care. His clinical practice is firmly grounded in scientific, evidence-based medicine, ensuring that patients receive treatment aligned with the latest global standards and research.
Dr. Aggarwal is known for his compassionate and patient-centric approach, emphasizing clear communication, trust, and individualized care. He believes that optimal outcomes are achieved by combining surgical excellence with empathy and holistic support throughout the patient’s journey.
OPD Timing: 09:00 AM – 05:00 PM
Alongside his clinical work, he is actively involved in teaching and academic activities, contributing to the training of future surgeons. He has authored multiple national and international publications in reputed journals and continues to engage in ongoing research.
He is also a recognized national faculty in GI and HPB malignancies, regularly invited to speak at conferences, workshops, and academic forums across the country.
Experience
Associate Director – GI & HPB Oncosurgery
BLK – Max Super Speciality Hospital · Full-time
Jul 2025 – Present
Delhi, India
Consultant – GI & HPB Oncosurgery
Rajiv Gandhi Cancer Institute and Research Centre · Full-time
Jan 2020 – Mar 2025 (5 years 3 months)
Delhi, India
Fellow – GI & HPB Oncosurgery
Rajiv Gandhi Cancer Institute and Research Centre
Jan 2019 – Dec 2019 (1 year)
Senior Resident – Surgical Gastroenterology
AIIMS (All India Institute of Medical Sciences), New Delhi · Full-time
Jul 2015 – Jun 2018 (3 years)
Delhi, India
Education
MCh – Surgical Gastroenterology
All India Institute of Medical Sciences (AIIMS), New Delhi
2015 – 2018
MS – General Surgery
SMS Medical College, Jaipur
2010 – 2013
MBBS (Bachelor of Medicine, Bachelor of Surgery)
Dr. D. Y. Patil Medical College, Pune
2003 – 2009
Reasearch and publications
Meena L. N. , Aggarwal Abhishek , Jain Sanchit. Cotyledonoid Leiomyoma of Uterus. The Journal of Obstetrics and Gynecology of India (March–April 2014) 64(2):146–147
Abhishek Aggarwal, Sanchit Jain, LN Meena, Sumita A Jain, Lakshman : Validation of Boey’s score in predicting morbidity and mortality in peptic perforation peritonitis in North western India. Tropical Gastroenterology 2015;36(4):256–260
Sanchit Jain, Abhishek Agarwal, Lakshman Agarwal, Laxmi Narayan Meena, Sumita Jain. Randomized trial to compare efficacy of polyester mosquito net mesh with polypropylene mesh in inguinal hernia surgery in north western India. Arch Clin Exp Surg 2016;5: 200-205.
Razik A, Madhusudhan KS, Aggarwal A, Panwar R, Srivastava DN. Gastrointestinal Stromal Tumor of the Jejunum With Active Bleeding Demonstrated on Dual-Energy MDCT Angiography: A Case Report. Curr Probl Diagn Radiol. 2019 May-Jun;48(3):298-301.
Hyperthermic intraperitoneal chemotherapy in gall bladder cancer: a pilot study(Abstract). A. Aggarwal N. R. Dash, S. Pal, A. Sharma, S. Deo, P. Sahni. HPB 2018, 20 (S2), S295- S332.
Goel S, Aggarwal A, Iqbal A, Gupta M, Rao A, Singh S. 18-FDG PET-CT should be included in preoperative staging of gall bladder cancer. Eur J Surg Oncol 2020;46: 1711-1716
Sayed AI, Goel S, Aggarwal A, Singh S. Robot assisted minimally invasive esophagectomy: safety, perioperative morbidity and short-term oncological outcome-a single institution experience. J Robot Surg. 2021 Jul 6. doi: 10.1007/s11701-021-01274-9.
Singh S, Goel S, Aggarwal A, Iqbal A, Hazarika D, Talwar V. Combination of portal vein embolization and neoadjuvant chemotherapy for locally advanced gallbladder cancer requiring extended hepatectomy – A novel approach. Indian J Gastroenterol. 2021 Dec;40(6):580-589.
Iqbal SA, Goel S, Aggarwal A, Gupta N, Gupta M, Durga G, Talwar V, Singh S. Use of 18F Fluorodeoxyglucose Positron Emission Tomography Computed Tomography in Assessing Response to Neoadjuvant Chemoradiation and Its Impact on Survival in Esophageal Squamous Cell Carcinoma. J Gastrointest Cancer. 2020
Goel S, Aggarwal A, Iqbal A, Talwar V, Mitra S, Singh S. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India. World J Gastroenterol. 2021 Dec 7;27(45):7813-7830.
Aggarwal A, Goel S, Sayed AI, Goel V, Talwar V, Singh S. Interaortocaval Lymph Node Metastasis in Gall Bladder Cancer: Is It Regional Node or Metastatic Disease? J Gastrointest Cancer. 2023 Feb .
Timing of curative resection in incidental gall bladder cancer: does it really matter?Dr Suchita Chowdhury, DrNB,SurgicalOncology∙ Dr Abhishek Aggarwal, MCh GI Surgery ∙ Dr Shaifali Goel, DNB, GI Surgery ∙ Dr Sayed Assif Iqbal, DNB, Surgical Oncology ∙ Dr Shivendra Singh, MCh, GI Surgery. HPB 2024
Chowdhury S, Aggarwal A, Goel S, Goel V, Talwar V, Singh S. Gastric cancer with limited peritoneal metastasis: Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Indian J Gastroenterol. 2025 Oct;44(5):692-699.
Singh S, Aggarwal A, Goel S, Iqbal SA, Talwar V. Segment 4b/5 versus Wedge Resection for Gallbladder Adenocarcinoma: A Randomized Controlled Trial. Ann Surg. 2025 Sep 25
Lahiri A, Goel S, Aggarwal A, Iqbal SA, Mehta A, Batra U, Sethi J, Singh S. Robotic versus open esophagectomy: a propensity score-matched analysis from a tertiary cancer center in India. J Robot Surg. 2025 Oct 10;19(1):672.
Aggarwal M, Aggarwal A, Goel S, Goyal S, Garg P, Gupta G, Singh S. Prognostic Factors and Long-term Outcomes in Patients With Colorectal Peritoneal Metastases Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cohort Study From a Tertiary Care Center in India. Dis Colon Rectum. 2026 Jan 1;69(1):42-52.
Jaganathan K, Goel S, Aggarwal A, Iqbal A, Garg P, Singh S. Role of 18FDG PET-CT & MRI for Predicting Response to Neo-Adjuvant Therapy in Rectal Cancer. J Gastrointest Cancer. 2025 Nov 29;56(1):230
Lahiri A, Chowdhury S, Goel S, Assif Iqbal S, Aggarwal A, Garg P, Goel V, Talwar V, Sethi J, Singh S. Neoadjuvant therapy in gall bladder cancer improves resectability and survival: a prospective study. HPB (Oxford). 2026 Feb 2:S1365-182X(26)00016-X
Awards and presentations
Best oral paper award at state chapter (Rajasthan), ASICON( Association of surgeons of India annual conference) 2011.
Presented a paper titled “Enucleation and cavito-jejunostomy in patients with Insulinoma of the head of pancreas” at IHPBA India annual conference in January 2018, Pune.
Presnted a poster , “Safety and feasibility of hyperthermic intrapeirtoneal chemotherapy (HIPEC) in resectable gall bladder cancer: A pilot study” at ESSO – ISPSSM international conference on HIPEC 2018 , AIIMS, Delhi.
Presented a poster titled “ Non hepatic surgery in chronic liver disease: has surgery become any safer?” at ILS( International liver symposium) conducted by Medanta institute of liver transplantation in March 2018, Delhi.
Presnted a “Talking poster” titled , “Role of hyperthermic intrapeirtoneal chemotherapy (HIPEC) gall bladder cancer” at IHPBA world congress in Geneva, 2018.
Role of PET scan in gall bladder carcinoma. IHPBA India annual conference 2019, Jaipur. – special mention poster award.
Presented a poster titled “Role of radical surgery in gall bladder cancer patients with interaortocaval lymph node metastases” at IHPBA India annual conference 2021 held online.
Participated as faculty in 23rd ACRSI instructional course 2019, organised by Sir Gangaram hopsital Delhi.
Participated as panelist in Oncology forum annual meeting in December 2019, Delhi.
Participated as faculty in national GI Oncology webinar series organised by Max institute of cancer care on 15/12/2021.